STON2 inhibitors represent a class of chemical compounds designed to modulate the activity of the Stomatin-Like Protein 2 (STON2), a crucial molecular player in various cellular processes. STON2, a member of the stomatin protein family, is known for its involvement in membrane dynamics, vesicular trafficking, and ion channel regulation. The inhibitors targeting STON2 are meticulously crafted to interact with specific binding sites on the protein, exerting control over its functions. These compounds often possess distinctive structural features, allowing them to selectively engage with the active sites of STON2, thereby influencing its downstream cellular effects.
STON2 inhibitors are characterized by their ability to bind to the target protein through non-covalent interactions, such as hydrogen bonding, hydrophobic interactions, and electrostatic forces. The design of these inhibitors involves a detailed understanding of the three-dimensional structure of STON2 and the identification of key residues responsible for its activity. By interfering with the normal functioning of STON2, these inhibitors hold the potential to unravel insights into cellular processes that rely on the precise regulation of membrane-associated proteins.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Hydroxy-Dynasore | 1256493-34-1 | sc-364678 | 10 mg | $250.00 | ||
Dyngo-4a inhibits dynamin, a GTPase essential for endocytosis, thus potentially affecting STON2's role in synaptic vesicle recycling. | ||||||
Pitstop 2 | 1419320-73-2 | sc-507418 | 10 mg | $360.00 | ||
Pitstop 2 is a clathrin inhibitor, impacting clathrin-mediated endocytosis where STON2 is implicated. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $87.00 | 44 | |
Dynasore is another dynamin GTPase inhibitor, potentially affecting STON2's role in vesicle recycling. | ||||||
Dynamin Inhibitor II | 1119-97-7 | sc-203931 sc-203931A sc-203931B sc-203931C | 5 g 250 g 500 g 1 kg | $46.00 $82.00 $122.00 $194.00 | ||
MiTMAB inhibits dynamin, thereby potentially influencing STON2-related endocytosis. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $60.00 $108.00 | 21 | |
Chlorpromazine is known to inhibit clathrin-dependent endocytosis, thus could impact STON2 function. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
Monensin disrupts endosomal sorting and could thereby affect STON2's role in synaptic vesicle recycling. | ||||||
Tyrphostin A23 | 118409-57-7 | sc-3554 | 10 mg | $110.00 | 13 | |
Tyrphostin A23 inhibits tyrosine kinases and could indirectly affect STON2's role in endocytosis. | ||||||
Methyl-β-cyclodextrin | 128446-36-6 | sc-215379A sc-215379 sc-215379C sc-215379B | 100 mg 1 g 10 g 5 g | $25.00 $65.00 $170.00 $110.00 | 19 | |
Methyl-β-cyclodextrin extracts cholesterol from membranes, which can disrupt lipid rafts and potentially affect STON2's function in vesicle trafficking. | ||||||